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The Editorial on the Research Topic
Schizophrenia: Human and Animal Studies
Schizophrenia is a complex disorder with relatively stable prevalence rates estimated at about
0.5–1% (Saha et al., 2005). Schizophrenia is characterized by the occurrence of various
psychopathological symptoms that have been described as positive symptoms (delusions and
hallucinations), negative symptoms (apathy, lack of motivation, flat affect, poverty of speech, and
social withdrawal), disorganized symptoms (disorganized speech and behavior), and cognitive
impairment (Moustafa et al., 2016). Traditionally, cognitive impairment was thought to be evident
only in elderly deteriorated patients with schizophrenia; however, over the past 25 years, a body
of evidence challenged this view and showed that cognitive dysfunction is a core feature of
schizophrenia (O’Carroll, 2000; Weickert et al., 2000; Bora et al., 2010). Cognitive deficits can be
moderate to severe across several domains, including attention, working memory, verbal learning
and memory, and executive functions (Weickert et al., 2000; Bowie and Harvey, 2006). These
deficits pre-date the onset of psychosis and further decline in cognitive functioning is observed
in the course of illness in most patients (Trotta et al., 2015). Numerous rehabilitation programs
have been developed in order to alleviate the burden associated with cognitive impairment in
schizophrenia since cognitive deficits respond poorly to antipsychotic treatment (Tao et al., 2015).
Below we describe articles in this research topic (mostly focusing on cognitive studies in
schizophrenia), dividing them into human vs. animal studies.
HUMAN STUDIES OF SCHIZOPHRENIA
Rodriguez et al. investigated the effect of neuropsychological battery on global functioning and
quality of life in 36 first psychotic episode of schizophrenia spectrum disorder (FES) patients.
The results indicated that patients with FES were significantly impaired in both visuospatial and
verbal functioning compared to healthy controls. The authors concluded that the deficit in verbal
functioning was a better predictor of global functioning and quality of life than visuospatial
functioning.
Chen et al. investigated the nature of prospective memory using event-related brain potentials
in 20 symptomatically remitted patients with schizophrenia and 20 healthy controls. The
results indicated that patients with schizophrenia performed worse on the prospective memory
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task compared to the healthy controls. In particular, the
prospective positivity amplitude was significantly attenuated in
symptomatically remitted schizophrenia patients.
Schott et al. investigated whether dysfunctional processing of
novel information by the medial temporal lobe may be a possible
neural mechanism that contributes to the pathophysiology of
delusions. The authors used fMRI to examine 16 unmedicated
patients with paranoid schizophrenia and 20 age-matched
healthy controls. Participants completed a visual target detection
task that consisted of novel and familiar stimuli, and a standard
and a target picture. All of the participants when shown the
novel images had activation in the hippocampus, but only healthy
controls showed a positive relationship between novelty-related
hippocampal activation and recognition memory performance
24 h later, indicating a role of the hippocampus in positive
symptoms.
Although previous research (Potvin et al., 2015) suggests that
socio-economic status is correlated with cognitive impairments
in patients with dementia and schizophrenia, education and
income variation may not be the only reasons for such a
correlation. Other possible factors include differing life choices,
occupations, and environments. The results of Potvin et al. (2015)
may lack some experimental control in terms of the dosage and
comparison of prescribed antipsychotics. Salem and Moustafa
discussed the implications of these findings.
Guell and Bernacer explored the following question: where in
the body shall we look for markers of mental disorders? They
propose that the constitution of the body’s sense organs may be
an indicator of mental characteristics. If so, these organs can be
affected by mental disorders such as schizophrenia. They suggest
the approach of looking for differences in the constitution of the
sense organs in order to diagnose mental disorders. Schwitzer
et al. provided an insightful commentary on Guell and Bernacer.
In their article, they discussed the role played by visual attention
in the occurrence of schizophrenia symptoms, focusing on retinal
and early visual processing deficits.
Wang et al. investigated the neural correlates of the thalamus
and examined whether thalamic resting state networks are
different in patients with schizophrenia. The authors used a
standard seed-based whole-brain correlation (72 patients with
schizophrenia, 73 healthy controls). Patients with schizophrenia
had enhanced thalamic connectivity with bilateral precentral
gyrus, dorsal medial frontal gyrus, middle occipital gyrus, and
lingual gyrus. These patients also had reduced connectivity
in bilateral superior frontal gyrus, anterior cingulate cortex,
inferior parietal lobe, and cerebellum. The findings indicated
that the thalamus is over-connected during resting state in
schizophrenia.
Schwab et al. investigated saccadic latency modulation in
patients with schizophrenia and their first-degree relatives.
Participants (13 patients with ICD-10 schizophrenia, 10 first
degree relatives, 24 controls) performed two visual tasks: a color
task and a Landolt ring orientation task. Saccadic latency was
measured with a video-based oculography. Results indicated that
saccadic latencies were not modulated by visual processing of
different content for patients with schizophrenia, but saccadic
latencies were modulated for relatives and health controls.
Hori et al. investigated the relationship between serum
BDNF levels and decision making. They compared patients with
schizophrenia (86) to healthy controls (51) in terms of their
decision making ability and serum BDNF levels. Scores on the
Iowa Gambling Task were lower for patients with schizophrenia
compared to the controls. There was a negative correlation
between the mean net scores on the final two blocks and serum
BDNF levels. The authors concluded that the poor performance
of patients with schizophrenia on the Iowa Gambling Task may
be related to impaired sensitivity to reward and punishment due
to depressive symptoms and reduced serum BDNF levels.
Frydecka et al. compared the level of working memory
impairments across patients with schizophrenia (n = 23),
psychotic bipolar disorder (n = 19), non-psychotic bipolar
disorder (n = 24), and healthy controls (n = 18). The results
indicated that on more demanding working memory measures
the group with schizophrenia and psychotic bipolar disorder
performed poorer than the non-psychotic bipolar disorder
group and healthy controls. There was a positive correlation
of working memory performance with antipsychotic treatment
and a negative correlation with depressive symptoms in bipolar
disorder and with negative symptoms in the schizophrenia
subgroup.
Zhuo et al. investigated changes in resting-state functional
connectivity density (rsFCD) in schizophrenia (n = 95) and
healthy controls (93). The results indicated that patients with
schizophrenia had increased rsFCD in the bilateral striatum and
hippocampus and decreased rsFCD in the bilateral sensorimotor
cortices and right occipital cortex.
Wotruba et al. investigated functional brain correlates in
the anticipation and reception of rewards and examined their
possible association with symptoms in unmedicated people at
risk for psychosis (n = 21) and healthy controls (n = 24). The
results indicated that the same brain areas were recruited during
processing of reward information in both at risk individuals and
healthy controls. In contrast, during the anticipating rewards
stage the at risk individuals showed additional activation in the
posterior cingulate cortex and the medio- and superior-frontal
gyrus.
Garbarini et al. investigated whether patients with
schizophrenia have an altered sense of agency during the
observation of others’ movements. A circles-lines task was used,
in which participants had to draw lines while observing an
examiner’s hand draw circles. Results indicated an interference
effect of the examiner’s hand drawing circles on their hand
drawing lines.
Moustafa et al. provided an overview of homocysteine
metabolism in psychiatric disorders with a focus on cognitive
correlates. Several biological mechanisms linking homocysteine
to biological underpinnings of psychiatric disorders were
discussed and future directions and perspectives were indicated.
ANIMAL STUDIES OF SCHIZOPHRENIA
Below, we summarize animal studies we covered in our research
topic.
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Falsafi et al. examined which GABAB-containing receptor
complexes are involved in a multiple T maze task. Twenty
trained and untrained mice were exposed to the multiple T maze
task. The results indicated that training increased GABAB1/1A
containing receptor complexes in the hippocampus.
Oliveras et al. investigated whether the Roman high-
avoidance inbred strain (RHA-I) display prepulse inhibition
(PPI) compared to Roman low-avoidance rats (RLA-I) and
genetically heterogenous (NIH-HS) rats. More specifically, they
examined whether PPI deficits predict spatial working memory
impairments. The results indicated that the RHA-I rats had PPI
and spatial working memory deficits compared to the other two
groups.
Nakao et al. examined the role of beta-anchoring and -
regulatory protein (BARP) in higher brain functions. BARP
knockout (KO) mice were generated and a comprehensive
behavioral test battery was undertaken. The results indicated that
these rats showed greatly reduced locomotor activity.
Gruter et al. investigated the cellular mechanisms that may
underlie hippocampal dysfunction in psychosis. Male Wistar rats
were treated with irreversible NMDAR-antagonist, MK801. After
4 weeks, the treatment led to the loss of hippocampal long-
term potentation (LTP). Expression of the early gene (Arc) was
enhanced in the hippocampus of controls by spatial learning. The
authors concluded that in psychosis, deficits in hippocampus-
dependent memory may be due to the loss of hippocampal LTP.
Niu et al. investigated whether the prepulse inhibition (PPI)
response can be disturbed by the blockage of olfactory input. The
results indicated that the PPI of the startle response was impaired
by the blockage of olfactory sensory input. Microinjection of
lidocaine/MK801 into the olfactory bulb impaired the PPI. The
authors concluded that the olfactory system plays a role in the
PPI of the startle response in rats.
Pinnock et al. investigated whether activate muscarinic and
potentially nicotine receptors (nAChRs) expressed by pontine
receptors are responsible for the nicotine enhancement
of prepulse inhibition (PPI). The results indicated that
nAChR antagonists had limited effects on PPI. However,
PnC microinfusions of the non-α7nAChR preferring antagonist
TMPH into the PnC significantly reduced PPI.
DeAngeli et al. investigated whether a change in the
concentration of kynurenic acid (KYNA; which is increased
in patients with schizophrenia) would affect reward related
behavior. The rats that were treated with L-kynurenine showed
increased sign-tracking behavior. The authors concluded that
exposure to KYNA may increase the salience of cues related to
reward. They also examined the effect of exposure to KYNA on
hippocampal long-term potentiation (LTP). After a burst of high-
frequency stimulation the rats treated with L-kynurenine showed
no LTP, whereas vehicle-treated rats showed robust LTP.
Richter et al. translated a human stability-flexibility paradigm
to mice. Mice were trained in a touchscreen-paradigm to
discriminate visual cues. Results provided evidence for the Dual
State Theory that assumes an antagonistic relation between
cognitive flexibility and stability.
Ding et al. investigated whether N-methyl-D-aspartate
receptor (NMDR) and Ca2+permeable α-amino-3-hydroxy-5-
methyl-4-isoxazole-propionic acid receptor (AMPAR) activation
in the striatum is necessary for cognitive flexibility. The findings
suggested that NMDR-mediated glutamate transmission in the
nucleus accumbens contributes more to cognitive execution than
the dorsal striatum.
In short, in this topic, we attempted to cover different aspects
of schizophrenia symptoms, using both human and animal
studies. The articles covered here explained the complexity
of behavioral and neural abnormalities in schizophrenia, and
further suggest future work in this area.
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